We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$6.25B
AUM Growth
+$1.16B
Cap. Flow
+$213M
Cap. Flow %
3.41%
Top 10 Hldgs %
36.07%
Holding
119
New
10
Increased
44
Reduced
39
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$118M
2
OTIS icon
Otis Worldwide
OTIS
+$115M
3
MDT icon
Medtronic
MDT
+$80M
4
META icon
Meta Platforms (Facebook)
META
+$37M
5
CL icon
Colgate-Palmolive
CL
+$31M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$82.3M
2
COST icon
Costco
COST
+$54.4M
3
MAR icon
Marriott International
MAR
+$39.2M
4
WY icon
Weyerhaeuser
WY
+$28.5M
5
BAP icon
Credicorp
BAP
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 15.8%
3 Consumer Discretionary 13.72%
4 Industrials 10.32%
5 Healthcare 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$244M 3.9%
1,198,163
+4,147
+0.3% +$753K
CL icon
2
Colgate-Palmolive
CL
$73.3B
$242M 3.87%
3,305,185
+436,889
+15% +$31M
AMZN icon
3
Amazon
AMZN
$2.53T
$234M 3.74%
1,694,780
+63,740
+4% +$7.7M
EQIX icon
4
Equinix
EQIX
$103B
$230M 3.67%
326,986
-17,422
-5% -$11.8M
AMGN icon
5
Amgen
AMGN
$209B
$228M 3.64%
966,165
-42,703
-4% -$9.74M
CME icon
6
CME Group
CME
$96.1B
$227M 3.63%
1,397,591
+59,504
+4% +$10.7M
MA icon
7
Mastercard
MA
$510B
$221M 3.53%
746,544
+8,841
+1% +$2.49M
ECL icon
8
Ecolab
ECL
$78.6B
$218M 3.49%
1,095,329
-40,875
-4% -$7.91M
ACN icon
9
Accenture
ACN
$99.9B
$208M 3.33%
970,250
-142,081
-13% -$26.9M
HD icon
10
Home Depot
HD
$332B
$204M 3.26%
812,653
+76,003
+10% +$17.4M
TSM icon
11
TSMC
TSM
$2.09T
$189M 3.02%
3,326,212
+220,329
+7% +$11.6M
DE icon
12
Deere & Co
DE
$162B
$166M 2.65%
1,054,063
-68,358
-6% -$9.91M
NEE icon
13
NextEra Energy
NEE
$183B
$158M 2.54%
2,639,572
-73,240
-3% -$4.38M
UPS icon
14
United Parcel Service
UPS
$89.5B
$153M 2.45%
1,376,491
+181,204
+15% +$18.1M
BABA icon
15
Alibaba
BABA
$279B
$150M 2.4%
695,365
+49,522
+8% +$10.3M
JPM icon
16
JPMorgan Chase
JPM
$933B
$148M 2.37%
1,576,371
-174,600
-10% -$16.6M
AVGO icon
17
Broadcom
AVGO
$1.85T
$148M 2.37%
4,694,200
+98,440
+2% +$2.76M
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.08T
$146M 2.34%
2,069,580
-346,020
-14% -$23.3M
ARMK icon
19
Aramark
ARMK
$15.1B
$143M 2.29%
8,768,461
+1,531,264
+21% +$26.9M
MRK icon
20
Merck
MRK
$321B
$140M 2.24%
1,901,816
+1,561,226
+458% +$118M
OTIS icon
21
Otis Worldwide
OTIS
$27.3B
$126M 2.02%
+2,220,859
New +$115M
MDT icon
22
Medtronic
MDT
$110B
$123M 1.97%
1,343,315
+834,189
+164% +$80M
SPLK
23
DELISTED
Splunk Inc
SPLK
$111M 1.77%
557,156
+116,455
+26% +$18.4M
SCI icon
24
Service Corp International
SCI
$11.7B
$105M 1.68%
2,705,313
-81,096
-3% -$3.11M
MCO icon
25
Moody's
MCO
$83.5B
$99.1M 1.59%
360,778
+98,302
+37% +$25M
1
2 3 4 5

Similar funds

PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Sarasin & Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Sarasin & Partners held 119 positions worth $6.25B, up 23% from $5.09B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sarasin & Partners deployed $213M of net new capital in Q2 2020, opening 10 new positions and adding to 44 existing holdings. Its largest new stake was Otis Worldwide: 2,220,859 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $82.3M trimmed.

  • Sarasin & Partners's largest Q2 2020 buy was Otis Worldwide: 2,220,859 shares worth $126M.
  • Sarasin & Partners added most to Merck in Q2 2020, an estimated $118M increase.
  • Sarasin & Partners's biggest Q2 2020 reduction was Pfizer, cutting an estimated $82.3M.
  • Sarasin & Partners fully exited Digital Realty Trust in Q2 2020, selling an estimated $5.78M.
  • Sarasin & Partners's ten largest holdings make up 36% of its $6.25B portfolio in Q2 2020.
  • Sarasin & Partners opened 10 new positions and closed 7 in Q2 2020.
  • Sarasin & Partners's portfolio value rose 23% quarter-over-quarter to $6.25B.

Based on Sarasin & Partners's 13F filing for Q2 2020, filed 17 Jul 2020.